Shift Characteristics Affect Handover Duration and Rates.

NCT02359071 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 267

Last updated 2015-11-20

No results posted yet for this study

Summary

The primary aim of our study was to analyze the independent factors affecting handover duration in Emergency Department. The secondary aim was to identify the factors affecting Emergency Department handover rates.

Conditions

  • Handover Duration

Interventions

OTHER

handover duration, handover rate

To better analyze independent variables, we dichotomized the data. First, we dichotomized handover duration into two groups according to the median handoff time of 20 minutes. Second, we divided handover rates into two groups using the median rate of handovers per shift, which was 3.87%.

Sponsors & Collaborators

  • Ankara Training and Research Hospital

    collaborator OTHER
  • Duzce university-DUZCE

    collaborator UNKNOWN
  • Recep Tayyip Erdoğan University-RIZE

    collaborator UNKNOWN
  • Mustafa Kemal University

    collaborator OTHER
  • DerinceTraining and Research Hospital- KOCAELI

    collaborator UNKNOWN
  • GATA Haydarpaşa Training Hospital, Istanbul

    collaborator OTHER
  • Ataturk University

    lead OTHER

Principal Investigators

  • Ali Karakus, Assoc. prof · Mustafa Kemal University

  • Ayhan Sarıtas, Assoc. prof · Duzce University

  • Gulhan Kurtoglu, specialist · Ankara Training and Research Hospital

  • Ozlem Bilir, Assist. Prof · Recep Tayyip Erdogan University

  • Ayhan Akoz, Assoc. prof. · Ataturk University

  • Murat Eroglu, Assoc. prof · GATA Haydarpasa Military Hospital

  • Onur Karakayali, specialist · DerinceTraining and Research Hospital

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2013-10-31
Completion
2013-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02359071 on ClinicalTrials.gov